MEDBOX | Toolbox Surveillance

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objective

Tags: Antimicrobial resistance, AMR, OneHealth, Guidelines, Monitoring and Evaluation,

Source: https://reliefweb.int/attachments/a0ac3d

Bulletin d’information de la Surveillance de la Résistance aux Antimicrobiens (RAM) au Mali

World Health Organization WHO (2023) C_WHO

En 2014, la soixante-septième Assemblée Mondiale de la Santé a exprimé sa préoccupation croissante au sujet de la situation de la RAM, et elle a exhorté les pays membres à renforcer leurs programmes d’action nationale ainsi que la collaboration internationale. Dans sa résolution WHA67.25 l’Organisation Mondiale de la Santé (OMS) a recommandé que soit développé un Plan d’Action Mondial pour lutter contre la RAM. Ce Plan a été adopté en mai 2015 et recommande notamment la mise en place d’un système mondial de surveillance de la RAM (GLASS, Global Antimicrobial Résistance Surveillance System). L’objectif de GLASS est de permettre la collecte, l’analyse et l’échange avec les pays de données standardisées, validées, comparables sur la résistance aux antimicrobiens

Tags: AMR, Résistance aux antimicrobiens, mali, surveillance,

Source: https://www.afro.who.int/sites/default/f

Global Antimicrobial Resistance and Use Surveillance System (GLASS)

World Health Organization WHO (2015) C_WHO

Antimicrobial resistance (AMR) represents a major threat to human health with significant global economic and security implications. In 2015, WHO Member States unanimously approved a Global Action Plan to tackle AMR (GAP-AMR). The goal of GAP-AMR is “to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them”

Tags: AMR, antimicrobial, OneHealth, global action plan,

Source: https://www.who.int/initiatives/glass

Surveillance of antimicrobial resistance in Europe 2020 data: executive summary

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Surveillance of antimicrobial resistance in Europe 2020 data: executive summary

Tags: AMR, Antimicrobial resistance, Surveillance Report, european commission, Europe,

Source: https://apps.who.int/iris/bitstream/hand

Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022

World Health Organisation (WHO) (2022) C_WHO

The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance of antimicrobial consumption (AMC), invasive fungal infections, and a One Health surveillance model relevant to human health. To meet future challenges, it is in continuous evolution to enhance the quality and representativeness of data to inform the AMR burden accurately. As of the end of 2022, 127 countries, territories and areas participate in GLASS. The fifth GLASS report, produced in collaboration with Member States, summarizes 2020 data on AMR rates in common bacteria from countries, territories, and areas. The report brings new features, including analyses of population testing coverage or AMR trends. For the first time, the report presents 2020 data on AMC at the national level. A new interactive dashboard allow users to explore AMR and AMC global data, country profiles and download the data. This report marks the end of the early implementation phase of GLASS. In addition to presenting data collected through the latest data call, this report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level. Patterns of antimicrobial consumption are presented by country with a particular focus on antibacterials. The report also presents the antimicrobial consumption according to the WHO AWaRe antibiotic classification, for penicillins and cephalosporines. From a One Health perspective, the report presents antimicrobial consumption data in the human sector expressed in tons to allow a comparison with antimicrobial consumption from other sectors (not included in this report)

Tags: AMR, One Health, antimicrobial,

Source: https://apps.who.int/iris/rest/bitstream

Training on GLASS methodology for national surveillance of antimicrobial consumption

World Health Organization WHO (2022) C_WHO

Tags: Antimicrobial resistance, Surveillance, consumption,

Source: https://apps.who.int/iris/bitstream/hand

The Center for Disease Dynamics Economics & olicy CDDEP (2022) CC

ResistanceMap is an interactive collection of charts and maps that summarize national and subnational data on antimicrobial use and resistance worldwide.

Tags: dashboard, AMR, Antimicrobial resistance, Surveillance and Epidemiology, antibiotic use, antimicrobials,

Source: https://resistancemap.cddep.org/

Data from the ECDC Surveillance Atlas - Antimicrobial resistance

European Centre for Disease Prevention and Control ECDC; WHO Europe (2022) CC

Interactive Atlas

Tags: Online Courses, AMR, Antimicrobial resistance, Surveillance, Europe,

Source: https://www.ecdc.europa.eu/en/antimicrob

Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021

World Health Organization WHO (2021) C_WHO

9 June 2021 Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth GLASS report. The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017. The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy

Tags: AMR, Antimicrobial resistance, Surveillance,

Source: https://apps.who.int/iris/rest/bitstream

Protocol for Enhanced Isolate-Level Antimicrobial Resistance Surveillance in the Americas. Primary Phase: Bloodstream Infections

Pan American Health Organisation PAHO (2021) C_WHO

Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy and interventions to combat AMR. Appropriate use of antimicrobials, informed by surveillance, improves patients’ treatment outcomes and reduces the emergence and spread of AMR. This protocol describes the steps and procedures to establish/enhance AMR surveillance in Latin America and the Caribbean

Tags: AMR, antimicrobial, Antimicrobial resistance, response plan, antibiotic stewardship, antibiotic resistance, antibiotic awarness, Latin America, Caribbean Region,

Source: https://iris.paho.org/bitstream/handle/1

	Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC View PDF(29) Download (24) Add to my MEDBOX Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objective Tags: Antimicrobial resistance, AMR, OneHealth, Guidelines, Monitoring and Evaluation, Source: https://reliefweb.int/attachments/a0ac3d
	Bulletin d’information de la Surveillance de la Résistance aux Antimicrobiens (RAM) au Mali World Health Organization WHO (2023) C_WHO View PDF(57) Download (36) Add to my MEDBOX En 2014, la soixante-septième Assemblée Mondiale de la Santé a exprimé sa préoccupation croissante au sujet de la situation de la RAM, et elle a exhorté les pays membres à renforcer leurs programmes d’action nationale ainsi que la collaboration internationale. Dans sa résolution WHA67.25 l’Organisation Mondiale de la Santé (OMS) a recommandé que soit développé un Plan d’Action Mondial pour lutter contre la RAM. Ce Plan a été adopté en mai 2015 et recommande notamment la mise en place d’un système mondial de surveillance de la RAM (GLASS, Global Antimicrobial Résistance Surveillance System). L’objectif de GLASS est de permettre la collecte, l’analyse et l’échange avec les pays de données standardisées, validées, comparables sur la résistance aux antimicrobiens Tags: AMR, Résistance aux antimicrobiens, mali, surveillance, Source: https://www.afro.who.int/sites/default/f
	Global Antimicrobial Resistance and Use Surveillance System (GLASS) World Health Organization WHO (2015) C_WHO Open external link (323) Add to my MEDBOX Antimicrobial resistance (AMR) represents a major threat to human health with significant global economic and security implications. In 2015, WHO Member States unanimously approved a Global Action Plan to tackle AMR (GAP-AMR). The goal of GAP-AMR is “to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them” Tags: AMR, antimicrobial, OneHealth, global action plan, Source: https://www.who.int/initiatives/glass
	Surveillance of antimicrobial resistance in Europe 2020 data: executive summary World Health Organization WHO, Regional Office of Europe (2021) C_WHO View PDF(82) Download (45) Add to my MEDBOX Surveillance of antimicrobial resistance in Europe 2020 data: executive summary Tags: AMR, Antimicrobial resistance, Surveillance Report, european commission, Europe, Source: https://apps.who.int/iris/bitstream/hand
	Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022 World Health Organisation (WHO) (2022) C_WHO View PDF(89) Download (41) Add to my MEDBOX The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance of antimicrobial consumption (AMC), invasive fungal infections, and a One Health surveillance model relevant to human health. To meet future challenges, it is in continuous evolution to enhance the quality and representativeness of data to inform the AMR burden accurately. As of the end of 2022, 127 countries, territories and areas participate in GLASS. The fifth GLASS report, produced in collaboration with Member States, summarizes 2020 data on AMR rates in common bacteria from countries, territories, and areas. The report brings new features, including analyses of population testing coverage or AMR trends. For the first time, the report presents 2020 data on AMC at the national level. A new interactive dashboard allow users to explore AMR and AMC global data, country profiles and download the data. This report marks the end of the early implementation phase of GLASS. In addition to presenting data collected through the latest data call, this report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level. Patterns of antimicrobial consumption are presented by country with a particular focus on antibacterials. The report also presents the antimicrobial consumption according to the WHO AWaRe antibiotic classification, for penicillins and cephalosporines. From a One Health perspective, the report presents antimicrobial consumption data in the human sector expressed in tons to allow a comparison with antimicrobial consumption from other sectors (not included in this report) Tags: AMR, One Health, antimicrobial, Source: https://apps.who.int/iris/rest/bitstream
	Training on GLASS methodology for national surveillance of antimicrobial consumption World Health Organization WHO (2022) C_WHO View PDF(77) Download (41) Add to my MEDBOX Tags: Antimicrobial resistance, Surveillance, consumption, Source: https://apps.who.int/iris/bitstream/hand
	ResitanceMap The Center for Disease Dynamics Economics & olicy CDDEP (2022) CC Open external link (467) Add to my MEDBOX ResistanceMap is an interactive collection of charts and maps that summarize national and subnational data on antimicrobial use and resistance worldwide. Tags: dashboard, AMR, Antimicrobial resistance, Surveillance and Epidemiology, antibiotic use, antimicrobials, Source: https://resistancemap.cddep.org/
	Data from the ECDC Surveillance Atlas - Antimicrobial resistance European Centre for Disease Prevention and Control ECDC; WHO Europe (2022) CC Open external link (631) Add to my MEDBOX Interactive Atlas Tags: Online Courses, AMR, Antimicrobial resistance, Surveillance, Europe, Source: https://www.ecdc.europa.eu/en/antimicrob
	Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021 World Health Organization WHO (2021) C_WHO View PDF(79) Download (66) Add to my MEDBOX 9 June 2021 Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth GLASS report. The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017. The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy Tags: AMR, Antimicrobial resistance, Surveillance, Source: https://apps.who.int/iris/rest/bitstream
	Protocol for Enhanced Isolate-Level Antimicrobial Resistance Surveillance in the Americas. Primary Phase: Bloodstream Infections Pan American Health Organisation PAHO (2021) C_WHO View PDF(155) Download (106) Add to my MEDBOX Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy and interventions to combat AMR. Appropriate use of antimicrobials, informed by surveillance, improves patients’ treatment outcomes and reduces the emergence and spread of AMR. This protocol describes the steps and procedures to establish/enhance AMR surveillance in Latin America and the Caribbean Tags: AMR, antimicrobial, Antimicrobial resistance, response plan, antibiotic stewardship, antibiotic resistance, antibiotic awarness, Latin America, Caribbean Region, Source: https://iris.paho.org/bitstream/handle/1